Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Rain Oncology Inc. (RAIN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2023 4 Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 266,500 options to buy @ $1.21, valued at $322.5k
Granted 133,250 options to buy @ $1.21, valued at $161.2k
08/11/2023 4 Doebele Robert (See Remarks) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 99,400 options to buy @ $1.21, valued at $120.3k
Granted 49,700 options to buy @ $1.21, valued at $60.1k
08/11/2023 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 35,000 options to buy @ $1.21, valued at $42.4k
08/11/2023 4 Radovich Peter (Director) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 35,000 options to buy @ $1.21, valued at $42.4k
08/11/2023 4 Nguyen Tran (Director) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 35,000 options to buy @ $1.21, valued at $42.4k
08/11/2023 4 Wolff Stefani (Director) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 35,000 options to buy @ $1.21, valued at $42.4k
08/11/2023 4 Hrustanovic Gorjan (Director) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 35,000 options to buy @ $1.21, valued at $42.4k
08/11/2023 4 Davis Aaron I. (Director) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 35,000 options to buy @ $1.21, valued at $42.4k
08/11/2023 4 Atkisson Erik (General Counsel and CCO) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 60,251 options to buy @ $1.21, valued at $72.9k
08/11/2023 4 Bruce Josephine (Principal Fin. & Acc. Officer) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 10,800 options to buy @ $1.21, valued at $13.1k
06/09/2023 3 Bruce Josephine (Principal Fin. & Acc. Officer) has filed a Form 3 on Rain Oncology Inc.
06/01/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on Rain Oncology Inc.
Txns: Bought 347,932 shares @ $1.05, valued at $365.3k
Bought 200,000 shares @ $1, valued at $200k
Bought 32,890 shares @ $1.06, valued at $34.9k
Bought 2,016 shares @ $1.08, valued at $2.2k
Bought 5,930 shares @ $1.06, valued at $6.3k
Bought 161,180 shares @ $1.08, valued at $174.1k
Bought 5,000 shares @ $1.1, valued at $5.5k
Bought 92,984 shares @ $1.09, valued at $101.4k
Bought 240,341 shares @ $1.12, valued at $269.2k
06/01/2023 3 TANG KEVIN C (10% Owner) has filed a Form 3 on Rain Oncology Inc.
05/24/2023 4 Boxer Capital, LLC (Director) has filed a Form 4 on Rain Oncology Inc.
Txns: Sold 995,000 shares @ $1.25, valued at $1.2M
11/23/2022 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Bought 45,000 shares @ $7.8, valued at $351k
Bought 77,000 shares @ $8.27, valued at $636.8k
11/08/2022 4 Davis Aaron I. (Director) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Bought 972,212 shares @ $5.83, valued at $5.7M
Bought 400,000 options to buy @ $5.83, valued at $2.3M
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Bought 25,000 shares @ $2.29, valued at $57.3k
04/15/2022 4 Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Gifted 59,618 shares @ $0
Gifted 59,618 shares @ $0
04/15/2022 4 Doebele Robert (See Remarks) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Exercised 3,000 options to buy @ $3.95, valued at $11.9k
04/04/2022 4 Doebele Robert (See Remarks) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Exercised 2,000 options to buy @ $3.95, valued at $7.9k
03/15/2022 4 Vellanki Avanish (President and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Exercised 14,468 options to buy @ $4, valued at $57.9k
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2022 4 BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Bought 255,500 shares @ $12, valued at $3.1M
Bought 61,343 shares @ $11.9984, valued at $736k
Bought 226,079 shares @ $12, valued at $2.7M
Bought 14,806 shares @ $12, valued at $177.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy